64Indexed trials
mesh condition
Nervous System Diseases
Intelligence
Nervous System Diseases intelligence: 64 indexed trials, 19 recruiting studies, 64 sponsors across 43 countries.
19Recruiting
64Sponsors
43Countries
Leading sponsors
Affiris AG10 recruiting
Alberto Esquenazi11 recruiting
Anova Enterprises, Inc10 recruiting
Assistance Publique - Hôpitaux de Paris10 recruiting
Aziende Chimiche Riunite Angelini Francesco S.p.A11 recruiting
Beats Medical10 recruiting
Beijing Friendship Hospital10 recruiting
Burke Medical Research Institute11 recruiting
Danilo Toni10 recruiting
Eisai Co., Ltd.10 recruiting
Eisai Limited10 recruiting
Aarhus University Hospital10 recruiting
Geographic activity
United States34trials
France10trials
Italy10trials
Canada9trials
Spain6trials
United Kingdom5trials
Poland5trials
Germany5trials
China5trials
Czechia5trials
Sweden4trials
South Korea4trials
Leading interventions
E20202trials
Metformin2trials
Placebo Medication2trials
Administration of BMS-9863681trials
BPN147701trials
Betashot1trials
BGG4921trials
Brexpiprazole, OPC-347121trials
COVID-19 swap test PCR1trials
Cedrus RB series response pad; Adtech Behnke-Fried micro-electrodes; Neuralynx or Blackrock electrophysiology system; Blackrock Cerestim or Natus Nicolet stimulator1trials
Cerebral Dopamine Neurotrophic Factor1trials
Botulinum toxin type A1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.